Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Net Equity Issued and Repurchased (2015 - 2018)

Viking Therapeutics' (VKTX) quarterly Net Equity Issued and Repurchased came in at $165.2 million in Q3 2018, up 13116.4% year-over-year from N/an in Q3 2017, and up 180.86% quarter-over-quarter from $58.8 million in Q1 2018.

Analysis

Viking Therapeutics (VKTX) Net Equity Issued and Repurchased (2015 - 2018) Analysis & Trends

Viking Therapeutics has disclosed Net Equity Issued and Repurchased across 4 years of filings, most recently posting $165.2 million for Q3 2018.

  • In Q3 2018, Net Equity Issued and Repurchased rose 13116.4% year-over-year to $165.2 million; the TTM figure through Dec 2018 stood at $225.3 million (changed N/A YoY), while the FY2018 annual figure was $296.6 million, up 1226.98% from the prior year.
  • Net Equity Issued and Repurchased came in at $165.2 million for Q3 2018 at Viking Therapeutics, up from $58.8 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $165.2 million in Q3 2018 to a low of $25772.0 in Q3 2016.
  • Average Net Equity Issued and Repurchased over 4 years is $26.6 million, with a median of $2.1 million recorded in 2016.
  • Year-over-year, Net Equity Issued and Repurchased slumped 66.33% in 2016 and jumped 13116.4% in 2018.
  • Over 4 years, Net Equity Issued and Repurchased stood at $6.3 million in 2015, then sank by 82.45% to $1.1 million in 2016, then climbed by 13.23% to $1.2 million in 2017, then jumped by 13116.4% to $165.2 million in 2018.
  • Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $165.2 million in Q3 2018, $58.8 million in Q1 2018, and $1.2 million in Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 6.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 9.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Viking Therapeutics 4.86 Bn 4.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 165.21 Mn
Mar 31, 2018 58.82 Mn
Sep 30, 2017 1.25 Mn
Jun 30, 2017 2.04 Mn
Mar 31, 2017 2.54 Mn
Dec 31, 2016 1.10 Mn
Sep 30, 2016 25,772.00
Jun 30, 2016 2.12 Mn
Jun 30, 2015 6.29 Mn
API Access

Viking Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VKTX&period=max&api_key=YOUR_API_KEY